-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

635.P1.18 635. Myeloproliferative Syndromes: Basic Science: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Biological, Animal models, Diseases, Combinations, Therapies, Biological Processes, MPN, Polycythemia vera, Technology and Procedures, epigenetics, thrombocythemia, Study Population, Clinically relevant, Myeloid Malignancies, RNA sequencing
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Shunichiro Yasuda, MD1,2*, Satoru Aoyama, M.D.1,2*, Ryoto Yoshimoto, Student2*, Daisuke Watanabe, M.D., Ph.D.1*, Hiroki Akiyama, M.D., Ph.D.2*, Kouhei Yamamoto3*, Takeo Fujiwara, MD4*, Emiko Sakaida, MD, PhD5, Yoko Edahiro, MD, PhD6*, Misa Imai, PhD6*, Marito Araki, PhD7*, Norio Komatsu, MD, PhD6 and Norihiko Kawamata, M.D., Ph.D.1

1Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
2Department of Hematology, TMDU, Tokyo, Japan
3Department of Comprehensive Pathology, TMDU, Tokyo, Japan
4Department of Global Health Promotion, TMDU, Tokyo, Japan
5Department of Hematology, Chiba University Hospital, Chiba City, Japan
6Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan
7Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan

Hamza Celik, PhD1, Ethan Krug1*, Hassan Bjeije, PhD1*, Nancy Issa, MD1*, Wentao Han1*, Won Kyun Koh1, Ruochao CZ Zhang, PhD1, Maggie J. Allen1*, Terrence N Wong, MD, PhD2, Daniel AC Fisher, PhD1*, Tiandao Li1*, Stephen T. Oh, MD, PhD1 and Grant A. Challen, PhD1

1Washington University in St Louis - School of Medicine, ST LOUIS, MO
2University of Michigan - Division of Hematology/Oncology, Ann Arbor, MI

Wenxue Ma, MD, PhD1*, Larissa Balaian, PhD2*, Phoebe Mondala, BS3*, Yudou He, BS4*, Cayla Mason, BS3*, Jessica Pham, B.S.3,5*, Jeremy Lee, BS4*, Raymond Diep, BS3*, Sanja Coso, PhD6*, Kathleen Fisch, PhD7*, Adam Mark, MS8*, Sheldon Morris, MD, MPH2*, Qingfei Jiang, PhD3,9, Thomas Whisenant, PhD7*, Aleksandra Rizo, MD, PhD10, Fei Huang, PhD11*, Mary Donohoe, PhD6*, Ludmil Alexandrov, PhD4* and Catriona Jamieson, MD, PhD3,12,13,14,15

1Department of Medicine, Moores Cancer Center, and Sanford Stem Cell Clinical Center, University of California San Diego, La Jolla, CA
2Moores Cancer Center, University of California San Diego, La Jolla, CA
3Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA
4University of California San Diego, La Jolla, CA
5Division of Regenerative Medicine, University of California, San Diego, Tustin, CA
6Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, and Sanford Stem Cell Clinical Center, University of California San Diego, La Jolla, CA
7Center for Computational Biology and Bioinformatics, University of California San Diego, La Jolla, CA
8Center for Computational Biology & Bioinformatics (CCBB), University of California San Diego, La Jolla
9Division of Regenerative Medicine, UCSD, San Diego, CA
10Geron Corporation, Parsippany, NJ
11Geron Corporation, Menlo Park, CA
12Sanford Stem Cell Clinical Center, University California, San Diego, La Jolla, CA
13Professor of Medicine, University California, San Diego, La Jolla, CA
14CIRM Alpha Stem Cell Clinic, University California, San Diego, La Jolla, CA
15Moores Cancer Center, University of California, San Diego, La Jolla, CA

Raajit K. Rampal, MD, PhD1, Qin Yang2*, Richard P. Koche, PhD3*, Erin McGovern, BA1,4*, Christopher Famulare, MS4*, Rona Singer Weinberg, PhD5, John Mascarenhas, MD1,6, Ross L. Levine, MD1,4,7,8,9, Ronald Hoffman, MD1,6 and Maria E. Figueroa, MD10,11

1MPN Research Consortium, New York, NY
2University of Miami, Sylvester Cancer Center, Miami
3Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York City, NY
4Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
5New York Blood Center, New York, NY
6Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
7Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
8Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
10Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
11Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL

Andrea Majoros, PhD1,2*, Harini Nivarthi3*, Ruochen Jia, PhD1,2*, Roland Jäger, PhD1*, Sarada Achyutuni1,2*, Christina M. Schueller2* and Robert Kralovics, PhD1,2

1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
3Cemm, Vienna, Austria

Ernesto J Cuenca, PhD Student1*, Nieves García Gisbert, BSc2*, Ascensión M de Los Reyes-García, PhD Student1*, Cristina Aroca, MD1*, Lorena Martinez-Montesinos, MD1*, Marcio Andrade, MD, PhD3,4*, Sonia Aguila, PhD1*, Pedro J Guijarro-Carrillo1*, Rosa Cifuentes-Riquelme, PhD Student1*, Rocio González-Conejero, PhD1*, Constantino Martínez, PhD1*, Vicente Vicente, MD, PhD1,5*, Alberto Alvarez-Larrán, MD2*, Beatriz Bellosillo, PhD4,6*, Raul Teruel-Montoya, PhD1,5,7* and Francisca Ferrer Marin, MD, PhD1,5,7*

1Unidad de Hematología y Oncología Médica. Hosp. Univ. Morales-Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
2Grup de Recerca Clínica, Aplicada en Neoplàsies Hematològiques-Hospital del Mar-IMIM. Pompeu Fabra University, Barcelona, Spain
3Hematology Department, Hospital del Mar, Barcelona, Spain
4Group of Applied Clinical Research in Hematology. Cancer research program-IMIM, Barcelona, Spain
5CIBERER (U-765), Murcia, Spain
6Pathology Department-IMIM, Universidad Pompeu Fabra, Hospital del Mar, Barcelona, Barcelona, ESP Group of Applied Clinical Research in Hematology. Cancer research program-IMIM, Barcelona, Spain
7UCAM, Murcia, Spain

*signifies non-member of ASH